$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
多吉美的作用及功效是什么?多吉美有什么副作用?
2025-10-19 11:44:20
Check Details
FDA授予LioCyx-M004治疗乙肝相关肝细胞癌的快速通道指定资格
2025-10-19 11:44:20
Check Details
来恩生物TCR-T疗法获FDA快速通道,什么是TCR-T?
2025-10-19 11:44:20
Check Details
瑞格非尼从哪里买比较便宜?九江可以购买到吗?
2025-10-19 11:44:20
Check Details
多靶点药物乐伐替尼效果究竟有多好?
2025-10-19 11:44:20
Check Details
北京还没买到乐伐替尼的患者快看这里!
2025-10-19 11:44:20
Check Details
多吉美对于肝癌晚期患者到底有多好?
2025-10-19 11:44:20
Check Details
肝癌首个靶向药物:多吉美
2025-10-19 11:44:20
Check Details
肝内胆管癌新药derazantinib疾病控制率达74%!
2025-10-19 11:44:20
Check Details
晚期肝癌新选择:雷莫芦单抗
2025-10-19 11:44:20
Check Details
肝癌治疗进展:乐伐替尼联合TACE可以提高肝癌患者的生存率
2025-10-19 11:44:20
Check Details
瑞格非尼最新价格是多少?瑞格非尼可以医保报销吗
2025-10-19 11:44:20
Check Details
1
2
...
2896
2897
2898
2899
2900
2901
2902
...
4160
4161
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
2
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
3
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
4
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
5
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
6
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
7
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
8
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
9
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
10
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
11
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
12
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide